Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 5Sarcoma 1

Conditions

Sarcoma 9Rhabdomyosarcoma 4Rhabdoid Tumor 4Osteosarcoma 4Central Nervous System Neoplasms 4Brain Neoplasms 4Neuroectodermal Tumors, Primitive, Peripheral 3Neuroblastoma 3Medulloblastoma 3Testicular Neoplasms 2Testicular Germ Cell Tumor 2Spinal Cord Neoplasms 2Sarcoma, Ewing 2Ovarian Neoplasms 2Neoplasms, Germ Cell and Embryonal 2Kidney Neoplasms 2Choroid Plexus Neoplasms 2Carcinoma, Renal Cell 2Astrocytoma 2Wilms Tumor 1Urinary Bladder Neoplasms 1Teratoma 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Kaposi 1Retinoblastoma 1Recurrence 1Pinealoma 1Ovarian Germ Cell Cancer 1Optic Nerve Glioma 1

Interventions

Temozolomide 51Bevacizumab 23Radiotherapy 16Magnetic Resonance Spectroscopy 16Irinotecan 15Carmustine 12Erlotinib Hydrochloride 10Carboplatin 8Surgical Procedures, Operative 6O(6)-benzylguanine 6Imatinib Mesylate 6Filgrastim 6Cyclophosphamide 6Biopsy 6sargramostim 5aldesleukin 5X-Rays 5Thalidomide 5Phantoms, Imaging 5Chemotherapy, Adjuvant 52-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 5temsirolimus 4Topotecan 4Specimen Handling 4Sirolimus 4Radiation 4Peripheral Blood Stem Cell Transplantation 4Nuclear Medicine Department, Hospital 4Etoposide 4Cisplatin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioma × etoposide phosphate × Sarcoma × Clear all
NCT00613223 2013-02-20

Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas

Duke University

Phase 1 Completed
49 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡